课题基金 / 基金详情

A randomized trial to compare effectiveness of 4 months Rifampin (4 RIF) with 9 months Isoniazid (9 INH) in the prevention of active TB in children: The P4v9 Trial

A randomized trial to compare effectiveness of 4 months Rifampin (4 RIF) with 9 months Isoniazid (9 INH) in the prevention of active TB in children: The P4v9 Trial
一项比较 4 个月利福平 (4 RIF) 与 9 个月异烟肼 (9 INH) 预防儿童活动性结核病有效性的随机试验：P4v9 试验
批准号：
210714
负责人：
Menzies Richard
金额：
$74.57万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=210714&lang=en
关键词：
Child Health Global Health Latent Tb Infection Randomized Trail Tuberculosis Prevention Tuberculosis Treatment

项目摘要

项目成果

Menzies Richard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tuberculosis (TB) is spread by airborne transmission from adults with active contagious TB to children, especially those living in the same household. Once children are exposed and infected they are at very high risk to develop active TB - which can be le
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
  • 批准号：
    415507
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2019
  • 负责人：
    Menzies Richard
  • 依托单位：
    McGill University
Religious communities to end TB (ReCET)
  • 批准号：
    372880
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.42万
  • 财政年份：
    2017
  • 负责人：
    Menzies Richard
  • 依托单位：
    Stellenbosch University (South Africa)
Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.
Evaluation of potential biomarkers of successful treatment of latent tuberculosis
海外基金